To distinguish between the hereditary (Lynch syndrome) and the sporadic form, other methylations are analyzed by immunohistochemistry, including the BRAF gene (the common somatic V600E mutation), which is present in 40–60% of MSI positive tumours and in 69% of tumours with absence of MLH1, but never in Lynch syndrome [77]. Here, BRAF is linked to Lynch syndrome.